Early recurrence risk stratification of hepatocellular carcinoma receiving preoperative radiotherapy: Incorporating clinical and imaging features across treatment phases

doi:10.3748/wjg.v32.i23.118308

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 23

This Article

(24)

(64)

(0)

(518)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jun 21, 2026; 32(23): 118308
Published online Jun 21, 2026. doi: 10.3748/wjg.v32.i23.118308

Full Size Figure Download Figure

Figure 3 Performance of the prognostic models. A: Time-dependent areas under the curves of the prognostic models at various time points; B: Calibration curves for the baseline-preoperative model for predicting 6-, 12-, and 18-month early recurrence-free survival; C: Calibration curves for the postoperative combined model for predicting 6-, 12-, and 18-month early recurrence-free survival. AUC: Area under the curve.

Citation: Cong R, Chen B, Cheng SN, Zhai YR, Wu F, Feng B, Wang LY, Chen ZW, Zhu YJ, Ma XH, Zhao XM. Early recurrence risk stratification of hepatocellular carcinoma receiving preoperative radiotherapy: Incorporating clinical and imaging features across treatment phases. World J Gastroenterol 2026; 32(23): 118308
URL: https://www.wjgnet.com/1007-9327/full/v32/i23/118308.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i23.118308

Cong R, Chen B, Cheng SN, Zhai YR, Wu F, Feng B, Wang LY, Chen ZW, Zhu YJ, Ma XH, Zhao XM. Early recurrence risk stratification of hepatocellular carcinoma receiving preoperative radiotherapy: Incorporating clinical and imaging features across treatment phases. World J Gastroenterol 2026; 32(23): 118308 [DOI: 10.3748/wjg.v32.i23.118308]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.